Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA
about
Activation of signalling by the activin receptor complexCloning and developmental expression of the chick type II and type III TGF beta receptorsThe latent transforming growth factor beta binding protein (LTBP) familyType I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activinHuman type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPsRETRACTED: TGFβ1 signaling via αVβ6 integrinOligomeric interactions of TGF-β and BMP receptorsCloning and characterization of a transmembrane serine kinase that acts as an activin type I receptorActivation of the murine type II transforming growth factor-beta receptor gene: up-regulation and function of the transcription factor Elf-3/Ert/Esx/Ese-1Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosisPositive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues.Disruption of TGF-beta growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization.Ultraviolet irradiation represses TGF-β type II receptor transcription through a 38-bp sequence in the proximal promoter in human skin fibroblasts.Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases.TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cellsCo-administration of cyclosporine an alleviates thioacetamide-induced liver injury.Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth suppression in the Lewis lung carcinoma cell linesComplementation between kinase-defective and activation-defective TGF-beta receptors reveals a novel form of receptor cooperativity essential for signaling.Acquired genetic and functional alterations associated with transforming growth factor beta type I resistance in Hep3B human hepatocellular carcinoma cell line.Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell lineLoss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.The types II and III transforming growth factor-beta receptors form homo-oligomers.Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane.Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanismIn vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosisInactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell linesTwo distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex.Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells.GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A.The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesodermReconstitution and transphosphorylation of TGF-beta receptor complexes.5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.Sp3 is a transcriptional repressor of transforming growth factor-beta receptors.Regulation of transforming growth factor-beta-receptor type I and type II messenger ribonucleic acid expression in the hamster ovary by gonadotropins and steroid hormones.Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
P2860
Q24308084-22E99BB7-AA74-4E6D-B8DE-98E95AFB7969Q24311670-5949F44D-E842-41AC-8A91-12B45DC5D0E5Q24532213-0A479830-43BA-4BBC-9E05-7F8BF478C281Q24612297-F11C51AA-12F0-488B-A4C9-A481D9E4EA03Q24651958-35D76CA1-DE4A-49ED-A939-90E424869DDEQ24795499-B9DB619A-AC3E-4BCF-B27A-C67C9F3B3BB8Q27023170-9C2017A3-CE6C-4087-BA22-71744B83E73EQ28580056-0963A209-5611-4FDE-A655-2B878112AF99Q28591649-D80A868A-73B7-4CEA-8A2D-FD960A1D34D5Q30436708-B6334FBD-17C2-45EE-9835-EC96F7BA8B56Q30699198-E3F058F8-FEC1-4773-9339-276F93F65E29Q31158693-502F0524-0628-4FFA-AAF6-64D22D782187Q33786347-D2FBD0BB-3844-4C80-BAB4-F825281371C9Q33886435-136948E7-4E9A-437A-AE71-94FDC2A5B076Q33929011-59224B79-349E-4301-A04F-A2D473596616Q34251932-65DA2D71-F428-49C0-B87D-9D09291A0F16Q34632777-E1F86D0E-F81E-41F9-B9CB-156A4CE9DC90Q34737426-A312951A-06B1-4878-8976-1D835D42B682Q35010389-3106117B-2799-46FF-A244-C01AEC39C2E6Q35787087-68989AA4-A281-44A5-A0BA-B26379F4C4C8Q35793694-C1E9E88E-DDC4-4BCC-8F25-D552E10F3EEBQ35843298-17C281D3-3AE5-4CE7-A0C3-2D95CA01B68AQ35893451-090F0E08-3C55-445F-882A-471AEB40339AQ35923870-98352B28-CF81-4D49-9E51-1F31A9D08397Q36160563-B0E3D4D8-9A66-4EDD-A4FD-849E1ABF76DFQ36234419-A9E77EEF-FB3E-400C-8F27-412339BD5487Q36235769-4FAACD95-C4D6-4EF4-8D61-503F309AA718Q36276659-A39C5C51-31E9-4BAC-AA48-3484C0001F40Q36370308-55791DD3-6D17-4891-8ED0-E45C7F14068AQ36553502-4351A2BA-34A7-41C4-A248-CA8276E99439Q36617606-3C54527B-80B9-458C-8AF7-78F61261C4F5Q36645287-80F8D397-3809-47DB-A5CC-04FD094E380AQ36665327-FD20850C-0663-4344-8A74-0D007F7D678DQ36712439-48270CA5-B815-4E1D-843F-126BF741E786Q36751599-0056FD38-2CEA-4548-927B-FF66DD0C2E25Q37639003-82034E4B-BFC3-4FEB-B2F0-705AEBA1A1C8Q38299216-1BB5C6B3-558A-4F0D-B3E0-AF6766AAFF67Q38307760-86BA9ACD-69C8-4835-A387-708705F303ABQ38312127-07F2EEC7-CC5B-4C0E-8829-E189978D7EF0Q38336378-D3761A3A-41FD-4D27-9D17-FFE56DAF30B1
P2860
Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Growth inhibition by transform ...... TGF-beta receptor type II cDNA
@ast
Growth inhibition by transform ...... TGF-beta receptor type II cDNA
@en
type
label
Growth inhibition by transform ...... TGF-beta receptor type II cDNA
@ast
Growth inhibition by transform ...... TGF-beta receptor type II cDNA
@en
prefLabel
Growth inhibition by transform ...... TGF-beta receptor type II cDNA
@ast
Growth inhibition by transform ...... TGF-beta receptor type II cDNA
@en
P2093
P2860
P356
P1476
Growth inhibition by transform ...... TGF-beta receptor type II cDNA
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.11.5359
P407
P577
1993-06-01T00:00:00Z